Skip to main content

Affinity Asset Advisors, LLC

Position in DNTH — Dianthus Therapeutics, Inc. /DE/

CIK 1773195 NEW YORK, NY

Position in DNTH

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$38,992,000
+$9,620,000 QoQ
Shares Held
400,000
+14.3% QoQ
Ownership
0.715%
of shares outstanding
% of Portfolio
1.97%
of 13F equity value
Holder Rank
#33
of 269 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DNTH Over Time

Shares Held

Position Value (USD)

Derivatives in DNTH

reported options exposure · as of Mar 31, 2026
CallValue
$4,196,000
CallShares
50,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Affinity Asset Advisors, LLC holds $1,842,784,374 across 87 Biotechnology names. DNTH ranks #15 (2.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in DNTH

Export CSV
5 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $38,992,000 400,000
2026-03-31 $4,196,000 50,000
2026-03-31 $29,372,000 350,000
2025-12-31 $4,739,150 115,000
2025-09-30 $10,313,635 262,100